Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat for acute respiratory distress syndrome
ChiCTR2400086486Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sivelestat in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Oxygenation index on day 7. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2400086486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086486.